In one-fifth of people with active tuberculosis (TB), the site of disease is outside the lungs (extrapulmonary TB). Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, ...
In one-fifth of people with active tuberculosis (TB), the site of disease is outside the lungs (extrapulmonary TB). Some forms of extrapulmonary TB, such as TB meningitis, are extremely dangerous, ...
This paper is an important addition to the literature. It represents the largest number of nonrespiratory samples tested with Xpert MTB/RIF of any study published to date and provides a much larger ...
GENEVA and SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which ...
The development of the Xpert MTB/RIF assay has been the most important breakthrough for the diagnosis of tuberculosis in decades. David L. Cohn This molecular-based test provides a rapid and sensitive ...
Please provide your email address to receive an email when new articles are posted on . Using a single sputum molecular test in place of serial sputum smear microscopy for inpatients undergoing ...
Tuberculosis (TB) causes more deaths globally than any other infectious disease and is a top 10 cause of death worldwide. Globally in 2017, of the estimated 10 million people with TB, 3.6 million were ...
A potential game-changer in the tuberculosis epidemic was how the tuberculosis community viewed rapid molecular tests for tuberculosis and tuberculosis drug resistance. This was 12 years ago, with the ...
Evaluation of: Tortoli E, Russo C, Piersimoni C et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. doi:10. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results